Arcoma Aktiebolag
ARCOMA SE0006219176
ICB 2010 : Health Care / Health CareAnnual Performance 1
2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
-50% | -34% | 19% | 29% | 1% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Person | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Lars Kvarnhem CEO |
7.00 SEK |
150,000 Bought |
1,050,000 SEK |
28/12/2023 | 27/12/2023 |
Mattias Leire CEO |
7.00 SEK |
14,400 Bought |
100,800 SEK |
22/12/2023 | 22/12/2023 |
Jan Wahlström DIR |
7.67 SEK |
70,000 Bought |
536,900 SEK |
16/12/2022 | 15/12/2022 |
Lars Kvarnhem CB |
8.80 SEK |
15,000 Bought |
132,000 SEK |
09/11/2022 | 09/11/2022 |
Mats Thoren DIR |
11.94 SEK |
10,000 Bought |
119,447 SEK |
11/02/2022 | 10/02/2022 |
Jesper Söderqvist DIR |
17.30 SEK |
190,000 Sold |
3,287,000 SEK |
29/06/2021 | 28/06/2021 |
Lars Kvarnhem CB |
18.50 SEK |
7,500 Bought |
138,750 SEK |
04/06/2021 | 04/06/2021 |
Nicklas Jan-olof Johansson O |
24.93 SEK |
4,029 Sold |
100,443 SEK |
14/01/2021 | 14/01/2021 |
Nicklas Jan-olof Johansson O |
24.60 SEK |
1,500 Sold |
36,900 SEK |
14/01/2021 | 13/01/2021 |
Johan Henningsson O |
25.00 SEK |
2,870 Sold |
71,750 SEK |
13/01/2021 | 13/01/2021 |